Target intelligence / Profile preview

Mitogen-activated protein kinase kinase kinase 13 (MAP3K13)

Target
MAP3K13
Molecular classification
Enzyme, Serine/threonine protein kinase, Kinase family: MAP kinase kinase kinase (MAP3K)
01

Overview

Mitogen-activated protein kinase kinase kinase 13 (MAP3K13) is a serine/threonine kinase enzyme involved in intracellular signal transduction pathways. It contains a dual leucine-zipper motif facilitating dimerization/oligomerization and phosphorylates downstream kinases such as MAP2K7/MKK7 and MAPK8/JNK, thereby activating the JNK signaling pathway. MAP3K13 also acts synergistically with PRDX3 to regulate NF-kappaB activation via the IKK complex. It is encoded by the *MAP3K13* gene on human chromosome 3q27.2 and is implicated in pathways such as TGF-beta and stress response. Associations with disease include cancer susceptibility, particularly glioma and carotid body tumors. It is categorized as a therapeutic target due to its role as an upstream regulator in major signaling pathways.

Other names
LZKLeucine zipper-bearing kinaseMixed lineage kinaseMEKK13MLK
02

Mechanism of action

Inhibition of kinase activity (for drugs like Fostamatinib); Downregulation of JNK and NF-kappaB pathway signaling

03

Biological functions

Signal transductionActivation of JNK (c-Jun N-terminal kinase) pathwayRegulation of NF-kappaB activationPhosphorylation of target proteins
04

Disease associations

Cancer (e.g., glioma susceptibility, carotid body cancer)Neurodegenerative disease (suggested by pathway roles, though not directly confirmed in search results)
05

Interacting drugs

Fostamatinib

Beyond the preview

Go deeper on Mitogen-activated protein kinase kinase kinase 13 (MAP3K13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 13 (MAP3K13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call